A Phase 2, Multi-Center, Randomized, Double-Blind, Place

Project: Research project

Project Details

Description

A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF THREE DOSAGE REGIMENS OF MP-376 SOLUTION FOR INHALATION GIVEN FOR 28 DAYS TO STABLE CYSTIC FIBROSIS PATIENTS
StatusFinished
Effective start/end date9/1/088/31/10

Funding

  • MPEX PHARMACEUTICALS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.